```html

Xerostomic Candida Pharyngitis

Overview

Xerostomic Candida pharyngitis (XCP) is an inflammatory infection of the throat (pharynx) caused by an overgrowth of the fungus Candida albicans in individuals who have reduced saliva production (xerostomia). The condition combines two common problems:

• Xerostomia – chronic dry mouth that diminishes the mouth’s natural antimicrobial defenses.
• Candida pharyngitis – fungal infection of the posterior oral cavity and pharynx.

XCP typically presents with painful, white or erythematous patches on the throat, a burning sensation, and difficulty swallowing. It most often affects adults over 50, people with systemic illnesses (diabetes, HIV, cancer), and anyone taking medications that lower salivary flow (anticholinergics, antihistamines, radiotherapy to the head‑and‑neck).

According to the Centers for Disease Control and Prevention (CDC), oral candidiasis affects up to 7 % of the general adult population, and the prevalence rises to >30 % among elderly nursing‑home residents who frequently suffer from xerostomia (CDC, 2022). While specific epidemiologic data for the combined “xerostomic Candida pharyngitis” are limited, clinicians estimate that 10–15 % of patients with chronic dry mouth develop a secondary Candida infection of the pharynx.

Symptoms

Symptoms can vary in intensity and may develop gradually over days to weeks. Common findings include:

Local throat symptoms

• Sore throat – persistent discomfort that may feel raw or burning.
• White, creamy plaques – often removable, leaving a red, sometimes bleeding surface.
• Redness (erythema) – inflamed mucosa of the oropharynx.
• Difficulty swallowing (odynophagia) – pain with solids or liquids.
• Feeling of a “lump” in the throat (globus sensation).

Dry‑mouth related symptoms

• Sticky or cotton‑like sensation in the mouth.
• Frequent thirst, especially at night.
• Cracked lips or oral mucosa.
• Difficulty speaking clearly.

Systemic or associated symptoms

• Low‑grade fever (rare, usually with extensive infection).
• Unexplained weight loss if swallowing becomes painful.
• Ear pain (referred pain from the throat).
• Bad breath (halitosis) caused by fungal metabolites.

Causes and Risk Factors

Primary cause

The fungus Candida albicans is a normal resident of the oral cavity in up to 40 % of healthy adults. In the presence of xerostomia, the protective antimicrobial actions of saliva—chiefly lysozyme, lactoferrin, and secretory IgA—are reduced, allowing Candida to proliferate and invade the pharyngeal epithelium.

Key risk factors

• Medications that reduce salivary flow – anticholinergics, antihistamines, antidepressants, diuretics, and certain antihypertensives.
• Radiation therapy to the head and neck (damages salivary glands).
• Systemic diseases – diabetes mellitus, HIV/AIDS, Sjögren’s syndrome, autoimmune disorders.
• Immunosuppression – chemotherapy, organ transplantation, chronic corticosteroid use.
• Poor oral hygiene – plaque buildup provides a niche for fungal colonization.
• Smoking & alcohol – irritate the mucosa and alter the microbiome.
• Dry environments – low humidity, mouth breathing, or use of mouth‑drying substances (caffeine, tobacco).
• Age – salivary gland function naturally declines after age 50.

Diagnosis

Accurate diagnosis combines a detailed history, physical examination, and targeted laboratory tests.

Clinical evaluation

• History of xerostomia, medication list, underlying illnesses.
• Visual inspection of the oropharynx with a tongue depressor and light source; plaques that can be gently scraped away are typical of Candida.

Laboratory tests

1. Oral swab culture – a sterile swab of the lesion is cultured on Sabouraud dextrose agar; growth of C. albicans confirms infection (sensitivity ≈ 90 %).
2. Fungal microscopy – potassium hydroxide (KOH) preparation shows pseudohyphae and budding yeast.
3. Salivary flow measurement – unstimulated flow < 0.1 mL/min is diagnostic of xerostomia (American Dental Association, 2021).
4. Blood glucose & HbA1c – to assess uncontrolled diabetes, a common co‑factor.
5. HIV screening – recommended for anyone with recurrent candidiasis.

Differential diagnosis

Other causes of sore throat must be ruled out: bacterial pharyngitis (Streptococcus), viral infections (EBV, HSV), allergic or irritant pharyngitis, lichen planus, and malignancy. If lesions persist despite antifungal therapy, a biopsy may be required to exclude dysplasia or carcinoma.

Treatment Options

Treatment targets both the fungal infection and the underlying dry‑mouth state.

Antifungal medications

Drug	Form	Typical Dose	Duration
Fluconazole	Oral tablet	100–200 mg daily	7–14 days
Clotrimazole	Troche (lozenge) or topical suspension	10 mg lozenge dissolve 5 times/day	7–10 days
Nystatin	Oral rinse	500,000 IU 4 times/day	7–14 days
Itraconazole	Oral	200 mg twice daily	14 days (for resistant cases)

For patients with hepatic impairment or drug interactions, topical agents (clotrimazole lozenges or nystatin swish‑and‑spit) are preferred (Mayo Clinic, 2023).

Managing xerostomia

• Saliva substitutes – over‑the‑counter sprays, gels, or lozenges containing carboxymethylcellulose or glycerin.
• Prescription sialagogues – pilocarpine (5 mg PO 3×/day) or cevimeline (30 mg PO 3×/day) to stimulate residual gland function.
• Hydration – sip water frequently; avoid caffeine, alcohol, and overly salty foods.
• Good oral hygiene – fluoride toothpaste, soft‑bristled toothbrush, antiseptic mouth rinses (e.g., 0.12 % chlorhexidine, short‑term).
• Humidifier – maintain indoor humidity ≥30 %.

Adjunctive measures

• Discontinue or replace xerogenic medications when possible – discuss alternatives with the prescribing clinician.
• Control blood glucose tightly (target HbA1c <7 %).
• Treat underlying immune suppression if feasible (e.g., reduce steroid dose).

Living with Xerostomic Candida Pharyngitis

Daily management tips

• Schedule regular oral rinses – 5 ml of saline or non‑alcoholic mouthwash 4–6 times daily.
• Maintain a saliva‑stimulating routine – chew sugar‑free xylitol gum for 10 minutes after meals.
• Track medication side‑effects – keep a list of drugs that cause dry mouth; request alternatives during clinic visits.
• Monitor symptoms – use a simple diary (date, pain score, any white patches) to spot early recurrence.
• Dietary adjustments – avoid acidic or spicy foods that irritate the throat; include probiotic‑rich foods (yogurt, kefir) to support a balanced oral microbiome.
• Dental follow‑up – see a dentist every 6 months for professional cleanings and evaluation of mucosal health.

When to contact your clinician

Call your healthcare provider if you notice any of the following:

• New or worsening white patches despite antifungal therapy.
• Persistent pain > 3 days after completing treatment.
• Difficulty swallowing liquids, weight loss, or fever.
• Side‑effects from antifungal meds (e.g., liver enzyme elevation, rash).

Prevention

• Identify and modify xerogenic triggers – switch to non‑drying antihistamines, limit caffeine, and use a humidifier.
• Regular dental care – plaque control reduces fungal colonization.
• Maintain optimal glycemic control – especially for diabetics.
• Vaccinations – annual flu shot and COVID‑19 vaccination decrease viral‑induced dry‑mouth episodes.
• Prophylactic antifungal use – may be considered for high‑risk patients (e.g., post‑radiation) under physician guidance.

Complications

If left untreated, xerostomic Candida pharyngitis can progress to:

• Chronic oral‑pharyngeal candidiasis – persistent infection that can spread to the esophagus.
• Esophageal candidiasis – presents with odynophagia, retrosternal pain, and may cause strictures.
• Secondary bacterial infection – damaged mucosa provides a portal for bacterial pathogens.
• Malnutrition – due to pain‑related avoidance of food.
• Increased risk of malignant transformation – chronic inflammation is a recognized risk factor for oral squamous cell carcinoma (Cleveland Clinic, 2022).

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Oral Candidiasis.” 2022. https://www.cdc.gov/fungal/diseases/candidiasis oral.html
2. Mayo Clinic. “Oral thrush (candidiasis).” Updated 2023. https://www.mayoclinic.org/...
3. National Institute of Diabetes and Digestive and Kidney Diseases. “Dry Mouth (Xerostomia).” 2021. https://www.niddk.nih.gov/...
4. World Health Organization. “Global burden of fungal diseases.” 2022. https://www.who.int/...
5. Cleveland Clinic. “Oral Candidiasis.” 2022. https://my.clevelandclinic.org/...
6. American Dental Association. “Saliva & Dry Mouth.” 2021. https://www.ada.org/...

```